Table II.

APP and Beclin-1 mRNA levels in the hippocampus by reverse transcription-quantitative PCR.

Groupa	APP	Beclin-1
Normal	1.00±0.00	1.00±0.00
Model	4.21±0.11c	3.81±0.09c
Low-dose β-asarone	1.42±0.04b,e,f,h	1.39±0.03b,e,g,h
Medium-dose β-asarone	1.77±0.07c,e,g,h	1.64±0.05b,e,g,h
High-dose β-asarone	2.06±0.08c,e,g,h	1.86±0.06c,e,g,h
3-MA	1.25±0.05b,e	1.15±0.03b,e
Rapamycin	2.82±0.13c,e,g	3.07±0.11c,d,g

^an=7 mice/group

^bP<0.05

^cP<0.01 vs. normal group

^dP<0.05

^eP<0.01 vs. model group

^fP<0.05

^gP<0.01 vs. 3-MA treated group

^hP<0.01 vs. rapamycin treated group. 3-MA, 3-methyladenine; APP, amyloid precursor protein.